AR036533A1 - Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos - Google Patents

Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos

Info

Publication number
AR036533A1
AR036533A1 ARP020103490A ARP020103490A AR036533A1 AR 036533 A1 AR036533 A1 AR 036533A1 AR P020103490 A ARP020103490 A AR P020103490A AR P020103490 A ARP020103490 A AR P020103490A AR 036533 A1 AR036533 A1 AR 036533A1
Authority
AR
Argentina
Prior art keywords
alkyl
compounds
cycloalkyl
hydrogen
urea
Prior art date
Application number
ARP020103490A
Other languages
English (en)
Spanish (es)
Inventor
Paula Nanette Belloni
Denis John Kertesz
Michael Klaus
Jean-Marc Lapierre
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR036533A1 publication Critical patent/AR036533A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP020103490A 2001-09-18 2002-09-16 Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos AR036533A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32296301P 2001-09-18 2001-09-18

Publications (1)

Publication Number Publication Date
AR036533A1 true AR036533A1 (es) 2004-09-15

Family

ID=33130243

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020103490A AR036533A1 (es) 2001-09-18 2002-09-16 Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos

Country Status (13)

Country Link
US (1) US6844466B2 (enExample)
EP (1) EP1430024A1 (enExample)
JP (1) JP4421293B2 (enExample)
KR (1) KR100896550B1 (enExample)
CN (1) CN1283621C (enExample)
AR (1) AR036533A1 (enExample)
AU (1) AU2002329276B2 (enExample)
BR (1) BR0212583A (enExample)
CA (1) CA2460693C (enExample)
MX (1) MXPA04002590A (enExample)
PL (1) PL370361A1 (enExample)
RU (1) RU2299877C2 (enExample)
WO (1) WO2003024921A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004251712A1 (en) * 2003-06-23 2005-01-06 Auspex Pharmaceuticals, Inc. Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
WO2005108338A1 (en) * 2004-05-03 2005-11-17 Auspex Pharmaceuticals Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
CN101146763A (zh) * 2005-03-30 2008-03-19 默克公司 胰高血糖素受体拮抗剂化合物、含有这种化合物的组合物以及使用方法
TW200821284A (en) * 2006-10-03 2008-05-16 Merck & Co Inc Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
CN111773213B (zh) 2010-09-01 2023-02-24 托马斯杰弗逊大学 用于肌肉修复和再生的组合物和方法
WO2014073209A1 (ja) 2012-11-08 2014-05-15 国立大学法人山口大学 角結膜障害の治療剤
KR101426197B1 (ko) * 2013-02-20 2014-08-01 여윤영 주먹밥틀
US10702502B2 (en) 2013-05-22 2020-07-07 Yamaguchi University Inhibitor for retinochoroidal disorders
CN105294567B (zh) * 2015-10-29 2018-10-09 湖北新烯王生物科技有限公司 取代的3-氟苯基甲醇类化合物、药物组合物及用途
ES2963348T3 (es) 2016-06-08 2024-03-26 Clementia Pharmaceuticals Inc Métodos para tratar la osificación heterotópica
JP7018957B2 (ja) 2016-11-16 2022-02-14 クレメンティア ファーマシューティカルズ インコーポレイテッド 多発性骨軟骨腫(mo)を処置するための方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87821A1 (fr) 1990-10-12 1992-05-25 Cird Galderma Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique
DE69333894D1 (de) * 1992-04-22 2005-12-01 Ligand Pharm Inc Verbindungen mit Retinoid x rezeptorselektivität
US6093742A (en) 1997-06-27 2000-07-25 Vertex Pharmaceuticals, Inc. Inhibitors of p38
JO2178B1 (en) * 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of emphysema using rar selective retinoid antagonists

Also Published As

Publication number Publication date
AU2002329276B2 (en) 2008-04-24
BR0212583A (pt) 2004-10-13
CN1555359A (zh) 2004-12-15
MXPA04002590A (es) 2004-06-18
CA2460693C (en) 2010-12-07
JP4421293B2 (ja) 2010-02-24
RU2299877C2 (ru) 2007-05-27
PL370361A1 (en) 2005-05-16
US20030158226A1 (en) 2003-08-21
RU2004111787A (ru) 2005-10-20
WO2003024921A1 (en) 2003-03-27
CN1283621C (zh) 2006-11-08
JP2005505571A (ja) 2005-02-24
CA2460693A1 (en) 2003-03-27
US6844466B2 (en) 2005-01-18
EP1430024A1 (en) 2004-06-23
KR20040035809A (ko) 2004-04-29
KR100896550B1 (ko) 2009-05-07

Similar Documents

Publication Publication Date Title
DOP2002000333A (es) Derivados de acido isoftalico como inhibidores de metaloproteinasas de la matriz
DE60335869D1 (de) 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
AR036659A1 (es) Compuestos derivados de fenil-piperazina, fenil-piperidina y fenil-tetrahidropiridina como inhibidores de la reabsorcion de la serotonina, una composicion farmaceutica y utilizacion de los mismos para la preparacion de medicamentos
CO5550421A2 (es) Derivados de indol utiles para el tratamiento de enfermeda- des
ECSP034691A (es) Inhibidores de piridina de metaloproteinasas de la matriz
CO5251381A1 (es) Derivados de adamantano, un proceso para su preparacion y composiciones farmaceuticas que los contienen
EA200500018A1 (ru) Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения
CA2497868A1 (en) Heterocyclic compounds
ATE297910T1 (de) Retinoid x rezeptormodulatoren
AR066972A1 (es) Derivados azapeptidicos
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
BRPI0409229A (pt) inibidores das fosfodiesterases na infertilidade
DOP2002000328A (es) Pirimidinas inhibidoras de metaloproteinasas de matriz
ATE280763T1 (de) Matrix-metalloproteinase-hemmer
DK1767535T3 (da) Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
AR033793A1 (es) Compuestos derivados del benceno, su utilizacion, procedimientos para su preparacion y composiciones farmaceuticas que los contienen
ATE332301T1 (de) Antivirale pyrazolopyridin verbindungen
AR045155A1 (es) Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
NO20071321L (no) Anti-inflammatoriske midler
DE60014394D1 (de) Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
DE602004026558D1 (de) Selektive nichtsteroidale glucocorticoid-rezeptor- modulatoren
CO5690551A2 (es) Derivados de tetrazol y metodos para el tratamiento con los mismos de trastornos relacionados con el metabolismo
AR054707A1 (es) Derivados de octahidropirrolo 3,4-c pirrol, un procedimiento para su preparacion, una composicion farmaceutica y uso del compuesto para la fabricacion de un medicamento
EA200700246A1 (ru) Трициклические производные пиразола в качестве модуляторов каннабиноидного рецептора